Primary Site >> Pancreatic Cancer
Gene >> ERCC2
|
|
|
|
|
|---|---|---|---|---|
|
Ref: A phase II trial of erlotinib in combination with gemcitabine and capecitabine in previously untreated metastatic/recurrent pancreatic cancer: combined analysis with translational research. PMID: 21404106 |
Ref: Prognostic factors in gemcitabine-cisplatin polychemotherapy regimens in pancreatic cancer: XPD-Lys751Gln polymorphism strikes back. PMID: 23390054 |
Ref: Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer. PMID: 26617894 |
Ref: Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population. PMID: 27050953 Ref: Association between ERCC1 and ERCC2 gene polymorphisms and susceptibility to pancreatic cancer. PMID: 27051038 |
Ref: Association between ERCC2 Lys751Gln polymorphism and the risk of pancreatic cancer, especially among Asians: evidence from a meta-analysis. PMID: 28223548 |